The European medicines regulator says that “unusual blood clots” should be listed as a “very rare” side-effect of the Oxford-AstraZeneca COVID vaccine.
‘Unusual blood clots’ should be listed as ‘very rare’ side effect of Oxford vaccine, EU regulator says